Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Iperboreal Pharma S.r.l.
Sponsor

Iperboreal Pharma S.r.l.

Italy Via L' Aquila 9, Abruzzo, 65121 Pescara, Italy

About the sponsor

Iperboreal Pharma S.r.l. focuses on end-stage kidney disease and treatments used in peritoneal dialysis, with research centered on dialysis solutions and approaches intended to support renal replacement therapy.

  • End-stage kidney disease
  • Peritoneal dialysis
  • Glucose-sparing dialysis solutions
  • Peritoneal ultrafiltration

The sponsor’s clinical portfolio includes investigations of dialysis-related therapies for patients initiating or continuing peritoneal renal support, with attention to kidney function management and treatment tolerability.

About Specializations

Iperboreal Pharma S.r.l. runs clinical trials in conditions such as End stage renal disease, Cardiac failure congestive, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

End stage renal disease

Recruiting

Study on the Safety and Effectiveness of PolyCore (Xylitol, L-Carnitine, Polydextrin) for Patients with End-Stage Kidney Disease Starting Peritoneal Dialysis

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Lactic Acid
  • Sponsor:Iperboreal Pharma S.r.l.

Cardiac failure congestive

Recruiting

Study on Peritoneal Ultrafiltration with PolyCore for Patients with Congestive Heart Failure Using Levocarnitine and Drug Combination

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Lactic Acid
  • Sponsor:Iperboreal Pharma S.r.l.

End stage renal disease

Recruiting

Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Iperboreal Pharma S.r.l.

End stage renal disease

Not yet recruiting

Study on the Safety of Glucothera Plus for Children with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Glucose Monohydrate
  • Sponsor:Iperboreal Pharma S.r.l.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.